Did Larsen & Toubro really win Rs 55,000Cr order? Official TenneT filing points to a different figure
Read More Pharma Industry News IDEAYA Biosciences (IDYA) stock in focus as ASCO 2026 late-breaker sets up fuller OptimUM-02 readout IDEAYA Biosciences heads to ASCO 2026 with full OptimUM-02 data. Read why the late-breaking slot could matter for IDYA stock and melanoma strategy. byVenkateshApril 21, 2026